Loading…

Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma: Neuroblastoma - Developmental and molecular biology meet therapy design

Saved in:

Bibliographic Details
Published in:	Cancer letters 2003, Vol.197 (1-2), p.225-230
Main Authors:	LANGE, B, SCHROEDER, U, HUEBENER, N, JIKAI, J, WENKEL, J, STRANDSBY, A, WRASIDLO, W, GAEDICKE, G, LODE, H. N
Format:	Article
Language:	English
Subjects:	Antineoplastic agents Biological and medical sciences Medical sciences Pharmacology. Drug treatments Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	230
container_issue	1-2
container_start_page	225
container_title	Cancer letters
container_volume	197
creator	LANGE, B SCHROEDER, U HUEBENER, N JIKAI, J WENKEL, J STRANDSBY, A WRASIDLO, W GAEDICKE, G LODE, H. N
description
format	article
fullrecord	<record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_15037018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15037018</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_150370183</originalsourceid><addsrcrecordid>eNqNjctKxEAQRRtxwPj4h9q4M9CxJySuRXEt7ocyXcn00OkKVTUD-XuD-AGuLpxz4F65qum757p76f21q3zw-zr0ob1xt6on732779rK2Sda4oI5rxBJ01QownGNwnm1NPxyHCxd0DZBxgtrigSLcJTzpE-AUPhCGdRka6YVRhawI4EJoc1UDHiEQmfh74xqPOO9242YlR7-9s49vr99vX7UC-p2OQqWIelhkTSjrIem9aHzTR_-2_0AyZJRWQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma: Neuroblastoma - Developmental and molecular biology meet therapy design</title><source>ScienceDirect Freedom Collection</source><creator>LANGE, B ; SCHROEDER, U ; HUEBENER, N ; JIKAI, J ; WENKEL, J ; STRANDSBY, A ; WRASIDLO, W ; GAEDICKE, G ; LODE, H. N</creator><creatorcontrib>LANGE, B ; SCHROEDER, U ; HUEBENER, N ; JIKAI, J ; WENKEL, J ; STRANDSBY, A ; WRASIDLO, W ; GAEDICKE, G ; LODE, H. N</creatorcontrib><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Medical sciences ; Pharmacology. Drug treatments ; Tumors</subject><ispartof>Cancer letters, 2003, Vol.197 (1-2), p.225-230</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15037018$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>LANGE, B</creatorcontrib><creatorcontrib>SCHROEDER, U</creatorcontrib><creatorcontrib>HUEBENER, N</creatorcontrib><creatorcontrib>JIKAI, J</creatorcontrib><creatorcontrib>WENKEL, J</creatorcontrib><creatorcontrib>STRANDSBY, A</creatorcontrib><creatorcontrib>WRASIDLO, W</creatorcontrib><creatorcontrib>GAEDICKE, G</creatorcontrib><creatorcontrib>LODE, H. N</creatorcontrib><title>Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma: Neuroblastoma - Developmental and molecular biology meet therapy design</title><title>Cancer letters</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Tumors</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNjctKxEAQRRtxwPj4h9q4M9CxJySuRXEt7ocyXcn00OkKVTUD-XuD-AGuLpxz4F65qum757p76f21q3zw-zr0ob1xt6on732779rK2Sda4oI5rxBJ01QownGNwnm1NPxyHCxd0DZBxgtrigSLcJTzpE-AUPhCGdRka6YVRhawI4EJoc1UDHiEQmfh74xqPOO9242YlR7-9s49vr99vX7UC-p2OQqWIelhkTSjrIem9aHzTR_-2_0AyZJRWQ</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>LANGE, B</creator><creator>SCHROEDER, U</creator><creator>HUEBENER, N</creator><creator>JIKAI, J</creator><creator>WENKEL, J</creator><creator>STRANDSBY, A</creator><creator>WRASIDLO, W</creator><creator>GAEDICKE, G</creator><creator>LODE, H. N</creator><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>2003</creationdate><title>Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma</title><author>LANGE, B ; SCHROEDER, U ; HUEBENER, N ; JIKAI, J ; WENKEL, J ; STRANDSBY, A ; WRASIDLO, W ; GAEDICKE, G ; LODE, H. N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_150370183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LANGE, B</creatorcontrib><creatorcontrib>SCHROEDER, U</creatorcontrib><creatorcontrib>HUEBENER, N</creatorcontrib><creatorcontrib>JIKAI, J</creatorcontrib><creatorcontrib>WENKEL, J</creatorcontrib><creatorcontrib>STRANDSBY, A</creatorcontrib><creatorcontrib>WRASIDLO, W</creatorcontrib><creatorcontrib>GAEDICKE, G</creatorcontrib><creatorcontrib>LODE, H. N</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LANGE, B</au><au>SCHROEDER, U</au><au>HUEBENER, N</au><au>JIKAI, J</au><au>WENKEL, J</au><au>STRANDSBY, A</au><au>WRASIDLO, W</au><au>GAEDICKE, G</au><au>LODE, H. N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma: Neuroblastoma - Developmental and molecular biology meet therapy design</atitle><jtitle>Cancer letters</jtitle><date>2003</date><risdate>2003</risdate><volume>197</volume><issue>1-2</issue><spage>225</spage><epage>230</epage><pages>225-230</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><cop>Shannon</cop><pub>Elsevier</pub></addata></record>
fulltext	fulltext
identifier	ISSN: 0304-3835
ispartof	Cancer letters, 2003, Vol.197 (1-2), p.225-230
issn	0304-3835 1872-7980
language	eng
recordid	cdi_pascalfrancis_primary_15037018
source	ScienceDirect Freedom Collection
subjects	Antineoplastic agents Biological and medical sciences Medical sciences Pharmacology. Drug treatments Tumors
title	Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma: Neuroblastoma - Developmental and molecular biology meet therapy design
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A40%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rationally%20designed%20hydrolytically%20activated%20etoposide%20prodrugs,%20a%20novel%20strategy%20for%20the%20treatment%20of%20neuroblastoma:%20Neuroblastoma%20-%20Developmental%20and%20molecular%20biology%20meet%20therapy%20design&rft.jtitle=Cancer%20letters&rft.au=LANGE,%20B&rft.date=2003&rft.volume=197&rft.issue=1-2&rft.spage=225&rft.epage=230&rft.pages=225-230&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E15037018%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_150370183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true